Register now for the Oklahoma Mothers and Newborns Affected by Opioids (OMNO) collaborative

Registration is now open for the Oklahoma Mothers and Newborns Affected by Opioids (OMNO) collaborative.  The goal of this collaborative is to Develop a standardized approach to identify and treat pregnant women with opioid use disorder as well as opioid-exposed newborns. OPQIC will select a small number of hospitals to participate in a pilot program in early 2020. Registration for this collaborative is a criteria for recognition as a Spotlight Hospital for 2019. Registration closes on August 31, 2019. For more information and to register, see the informational brochure.